Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.
1 other identifier
observational
360
1 country
1
Brief Summary
There is a rare condition causing scarring of the lungs termed interstitial lung disease. This comprises a group of conditions which can be divided into separate diseases. The aim of this study is compare a group of patients (the cases) with 2 types of this disease (fibrotic non-specific interstitial pneumonia (NSIP) and idiopathic pulmonary fibrosis (IPF)) with patients without the disease. The study will look at the 2 groups and their exposures to factors such as medications, smoking, previous jobs, previous medical problems and specifically heart disease and any operations or procedures involving the heart. There have been previous studies showing a link between heart disease and scarring of the lungs. This study will look at whether this association is stronger in one or the other type of lung scarring diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2010
CompletedFirst Posted
Study publicly available on registry
July 1, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedJuly 1, 2010
June 1, 2010
6 months
June 30, 2010
June 30, 2010
Conditions
Keywords
Study Arms (2)
Cases
Controls
Eligibility Criteria
Cases - patients with IPF or UIP. Controls - hospital clinic attenders.
You may qualify if:
- idiopathic fibrotic lung disease
You may not qualify if:
- non idiopathic fibrotic lung disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St George's Hospital
London, London, SW17 0QT, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 30, 2010
First Posted
July 1, 2010
Study Start
July 1, 2010
Primary Completion
January 1, 2011
Study Completion
April 1, 2011
Last Updated
July 1, 2010
Record last verified: 2010-06